Savara
SVRA
#6009
Rank
C$1.47 B
Marketcap
C$7.20
Share price
1.47%
Change (1 day)
120.94%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2025 (TTM): -C$0.17 Billion

According to Savara's latest financial reports the company's current earnings are N/A. a decrease over its 2024 earnings that were of -C$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2025

Annual earnings

Year Earnings Change
2025 -C$0.17 Billion23.94%
2024 -C$0.14 Billion75.29%
2023 -C$76.24 Million43.38%
2022 -C$53.18 Million-11.31%
2021 -C$59.96 Million-13.3%
2020 -C$69.16 Million-36.53%
2019 -C$0.11 Billion13.76%
2018 -C$95.78 Million105.54%
2017 -C$46.6 Million34.11%
2016 -C$34.75 Million-37.43%
2015 -C$55.54 Million38.81%
2014 -C$40.01 Million33.62%
2013 -C$29.94 Million38.49%
2012 -C$21.62 Million24.59%
2011 -C$17.36 Million-36.5%
2010 -C$27.33 Million-3.14%
2009 -C$28.22 Million-23.28%
2008 -C$36.78 Million8.52%
2007 -C$33.89 Million-34.14%
2006 -C$51.46 Million184.43%
2005 -C$18.09 Million90.75%
2004 -C$9.49 Million190.35%
2003 -C$3.27 Million11.64%
2002 -C$2.93 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.23 Billion 34.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$25.31 Million-84.72%๐Ÿ‡บ๐Ÿ‡ธ USA